SR1001 is primarily utilized in research and development within the field of biochemistry and pharmacology. It serves as a selective modulator for specific nuclear receptors, making it a valuable tool in studying receptor function and signaling pathways. This compound is often employed in preclinical studies to explore its potential therapeutic effects, particularly in metabolic disorders and inflammatory conditions. Its ability to influence gene expression and cellular responses makes it a candidate for drug discovery programs aimed at developing treatments for diseases like diabetes, obesity, and autoimmune disorders. Additionally, SR1001 is used in laboratory settings to investigate the molecular mechanisms underlying receptor-ligand interactions, contributing to advancements in targeted therapy development.